During the past decade, Department of Nuclear Medicine conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Nuclear Medicine" #1 collaborator was "Advanced Biochemical Compounds GmbH" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Department of Nuclear Medicine" are "Brain Tumor" (1 trials), "Head and Neck Cancer" (1 trials), "Head and Neck Neoplasms" (1 trials) and "Lung Cancer" (1 trials). Many other conditions were trialed in "Department of Nuclear Medicine" in a lesser frequency.

The vast majority of trials in "Department of Nuclear Medicine" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Department of Nuclear Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Department of Nuclear Medicine, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Nuclear Medicine, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".